Healthcare >> CEO Interviews >> December 2, 1999
VAUGHN M. KAILIAN has served as President, Chief Executive Officer and a
Director of COR Therapeutics, Inc. since March 1990. From 1967 to 1990,
Mr. Kailian was employed by Marion Merrell Dow, Inc., a pharmaceutical
company, and its predecessor companies, in various general management,
product development, marketing and sales positions, including President
and General Manager, Merrell Dow USA. He is currently a member of the
Pharmaceutical Foundation Advisory Council at both the University of
Texas at Austin and the University of Florida, and a Director of Amylin
Pharmaceuticals, Inc., AxyS Pharmaceuticals, the Biotechnology Industry
Organization and the California Healthcare Institute. Profile
Mr. Kailian: COR was founded in 1988 with R & D programs for acute and
chronic cardiovascular indications. Over the next decade, we
